Optimizing Longevity with Biomarkers
Chris Moore — Co-founder & CEO of the Nordic Group
Chris is a health entrepreneur and visionary. His purpose in life and business is to change healthcare and empower populations to take responsibilty for their own health. He has dedicated his career to growing the field of functional medicine. He has wide experience in laboratory analysis, nutritional supplements and medical clinic management. His company-Nordic Group is composed of several subsidiaries across Europe including: Nordic Laboratories, 5 Nordic Clinics, DNAlife, Nordic Health.
Chris Moore explores the future of personalized healthcare, emphasizing how diverse biomarkers,
Who owns your health? It is you. We all talk about having a right to go to the doctor when we are ill, but we also have an obligation to remain well and pursue the interventions that help us stay healthy.
Summary
- Individuals have a social responsibility and obligation to maintain their own health, prioritizing wellness and proactive interventions over a passive reliance on healthcare systems. - Health optimization is a lifelong journey (N=1) that requires continuous monitoring of personalized biological data sets like genetics, hormones, and the microbiome. - Advanced biomarkers, such as blood tests for 70+ solid tumors and pharmacogenomics for drug-gene interactions, allow for early disease detection and personalized medical treatments. - Rising antibiotic resistance is a critical global threat; individuals must exercise extreme caution with antibiotic use to prevent a projected 10 million deaths per year by 2050. - The Nordic Biohacker Experiment is a collaborative social project designed to track longitudinal health data and prove the efficacy of functional medicine interventions in a community setting.
Article
Optimizing Longevity With Biomarkers: Chris Moore’s Case For A New Social Contract In Health
At Biohacker Summit 2022 Helsinki, The Nordic Group Founder Argued That The Future Of Medicine Lay Not In Waiting For Disease, But In Tracking It Before It Began
In Helsinki on 3 June 2022, the entrepreneur Chris Moore took the stage at **Biohacker Summit 2022 Helsinki** with a proposition that felt at once radical and increasingly inevitable: healthcare, he said, had to move beyond treating illness after the fact and toward measuring the body long before it failed.
Moore’s presentation, **“Optimizing Longevity with Biomarkers,”** unfolded as both manifesto and invitation. Part lecture, part recruitment drive for what he called **The Nordic Biohacker Experiment**, it stitched together functional medicine, genetics, microbiome science, pharmacogenomics and longitudinal data into a single, insistent argument. If modern medicine had been built around averages, the next era would be built around the individual.
“This is the most important equation in medicine: N equals one,” Moore said. “We need to be challenging the status quo and demonstrating that the interventions we do really make a difference to our health.”
A Vision Forged Before The Mainstream Caught Up
Moore framed his argument through his own history. He described entering the field in the mid-1990s, when the notion that healthcare would become deeply personalized still sounded fringe, particularly outside major hospital systems. Yet the prediction, first delivered to him by a doctor in Copenhagen, stayed with him. In 1997, he founded what became the **Nordic Group**, a network that grew to include **Nordic Laboratories**, multiple **Nordic Clinics**, **DNAlife** and **Nordic Health** across Europe.
His biography helps explain the breadth of the presentation. Moore has spent his career moving through laboratory analysis, nutritional supplementation and clinic management, always orbiting one central conviction: that people should be empowered to take greater responsibility for their own health.
That conviction has since expanded into a wider European infrastructure, with clinics and laboratories spread across Copenhagen, Stockholm, Helsinki, Porto, Lisbon and Reykjavik, and further expansion planned at the time of the talk.
From Reactive Care To Predictive Medicine
The sharpest edge of Moore’s address came in his attack on reactive medicine. In his telling, traditional healthcare too often waited for a symptom, a lump, a crisis or a diagnosis before beginning its work. By then, opportunities had already narrowed.
“The future of healthcare is about being able to screen ourselves for disease manifestation before it has happened, giving us the knowledge that we are in a good space while issues are still manageable,” he said.
He pointed to emerging diagnostics that, he argued, were beginning to make that future tangible. Among them were blood-based tests capable of screening for more than 70 solid tumours, as well as pharmacogenomic analysis that could identify drug-gene interactions before a patient was prescribed medication likely to be ineffective or harmful.
The significance of pharmacogenomics, Moore suggested, had still not been fully absorbed by healthcare systems. The science was robust, he said, yet implementation remained slow. Still, he noted signs of change, including moves within the UK to integrate such testing more systematically.
His point was less that every new technology was already universal than that the architecture of future medicine was becoming visible. The old model of one treatment for all, he argued, was no longer intellectually defensible.
The Body As A Longitudinal Record
Running beneath the presentation was a deeper philosophical claim: that health was not a one-time achievement but a lifelong process of reading, interpreting and responding to biological signals.
“The journey to health optimization is a long one,” Moore said. “It is not going to happen next week or next month. This is ongoing; it is all through your life.”
That idea shaped every part of his framework. Genetics, hormones, stool testing, organic acids, allergies, microbiome analysis and wearable or implanted sensors were presented not as isolated tools but as pieces of a continuous record. The goal was to gather data over years and decades, building an increasingly precise picture of how one body, and not a statistical abstraction, changed over time.
In this account, health became a moving map rather than a binary state. Moore described his own decades of testing as an example of how longitudinal data could support resilience and course correction. The emphasis was not on perfection, but on pattern recognition.
The Intimate Politics Of Responsibility
What gave the talk its moral force was Moore’s insistence that health was not solely a private matter. Again and again, he returned to the idea of obligation.
“Individuals have a social responsibility and obligation to maintain their own health,” he argued, urging listeners to think beyond the right to access care and toward the duty to preserve wellness where possible.
It was a provocative line, especially in the aftermath of a pandemic that had intensified debates about state power, medical authority and personal autonomy. Moore gestured toward those tensions, questioning whether governments, doctors or families truly “owned” a person’s health. His answer was simple: the individual did.
Yet this was not merely libertarian rhetoric. It was tied to a broader claim about public systems under strain. Preventive care, in his formulation, was not only good for the self but necessary for the collective. If more people took active ownership of diet, exercise, mindfulness and biomarker monitoring, the burden on overworked doctors, nurses and bankrupting healthcare systems might ease.
The argument was stern, sometimes uncomfortably so. But it captured one of the summit’s defining tensions: biohacking as both self-optimization and civic ethic.
Genetics Before Conception, Not Just After Birth
Moore pushed the timeline of intervention back even further, arguing that optimization should begin before conception. If future parents wanted children to perform at their highest level, he said, they needed to examine genetics, hormones and the microbiome well in advance.
“If you want your children to perform at the highest level, you need to be looking at your genetics and hormones long before conception to provide the best environment for them to develop,” he said.
He referenced work connected to the **University of Las Vegas** and a methodology called **GrowBaby**, which uses maternal genetic testing to help predict how best to support a pregnancy to term and at normal birth weight. In Moore’s framing, such interventions were not marginal enhancements but foundational determinants of long-term disease risk.
This was perhaps the fullest expression of his worldview: biology as destiny only if left unread, but as opportunity if tracked early enough.
Antibiotic Resistance And The Warning In The Data
For all the futurism of the talk, one of its most urgent passages focused on an older and more immediate crisis: antibiotic resistance.
Moore cited figures suggesting that four million deaths in 2019 were directly linked to antibiotic failure, warning that the total could rise to 10 million annually by 2050. He urged extreme caution in antibiotic use and highlighted the Finnish company **Resistomap**, which monitors antibiotic-resistant bacteria.
The inclusion mattered. It prevented the presentation from drifting into a polished fantasy of elite optimization. Here was the counterpoint: even as precision medicine advanced, civilization still faced blunt microbial threats made worse by overuse, complacency and poor stewardship.
Food, Marketing And The Illusion Of Wellness
Moore also trained his criticism on the food industry and on consumers willing to be soothed by labels. Organic, gluten-free and health-branded products, he warned, could still be nutritionally empty or overloaded with sugar. Real health, he suggested, required scepticism as much as aspiration.
The same logic extended to supplementation. He singled out nucleotides as overlooked but fundamental building blocks of DNA, and discussed high-quality bone broth as a functional source of collagen and hyaluronic acid. These examples were not incidental product placements so much as extensions of his central belief that inputs matter, and that quality cannot be faked by marketing language.
The Black Swan In Medicine
At one point, Moore invoked Nassim Nicholas Taleb’s idea of the **Black Swan** to describe medicine’s resistance to paradigm change. For centuries, Europeans assumed black swans did not exist because they had never seen one. Then they were discovered in Australia, and certainty collapsed.
Medicine, Moore suggested, often behaved in the same way, clinging to inherited assumptions until reality forced a revision. Personalized diagnostics, functional medicine and predictive biomarker analysis belonged to that category of once-impossible things.
His challenge to the room was clear: do not wait 30 years for institutions to catch up. Test, measure, question and refine now.
The Nordic Biohacker Experiment As Collective Proof
The culmination of the presentation was **The Nordic Biohacker Experiment**, a community-based project designed to gather longitudinal health data and test the practical value of functional medicine interventions over time.
Moore was careful to say that it was not a clinical trial and not a mechanism for harvesting everyone’s private information. Instead, he described it as a collaborative social experiment, one in which participants could choose different levels of involvement, receive starter packs including genetic tests and supplements, join webinars, access discounted lab testing and become part of a health optimization community.
The ambition was larger than membership benefits. Moore wanted evidence, stories and shared trajectories that could show whether a community of motivated individuals, using biomarkers and personalized interventions, could become measurably healthier over a year and beyond.
In that sense, the experiment was also an argument against medical abstraction. It aimed to produce not just data points, but lived proof.
From The Internet Of Things To The Internet Of Everything
Perhaps the most revealing line of the talk came near the end, when Moore looked past current devices and into a more immersive future of integrated health data.
“Imagine what personalized healthcare can become as we move from the Internet of things to the Internet of everything,” he said.
It was a striking phrase, partly because it captured both the promise and the unease of the biohacking project. A future in which temperature chips, genetic reports, microbiome profiles, hormone panels and tumour screening all fed into one evolving portrait of the self might indeed transform care. It might also redraw the boundary between medicine and daily life entirely.
That, finally, was what Moore offered in Helsinki: not merely a better test or a smarter supplement, but a new way of imagining the human body. Less a patient waiting to be rescued than a system to be continuously understood.
At **Biohacker Summit 2022 Helsinki**, Chris Moore made the case that longevity would belong to those willing to measure it, question it and work at it for life. Whether that future proves liberating, demanding or both, his message was unmistakable. The age of passive healthcare, he suggested, was already beginning to look old.
Part of Biohacker Summit 2022 Helsinki